Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical device directive: preparing for the amendments.

M Donawa1

  • 1Donawa and Associates Ltd, Rome, Italy. donawa@srd.it

Medical Device Technology
|August 1, 2000
PubMed
Summary

Article 21 of the In Vitro Diagnostic (IVD) Directive amends the Medical Device (MD) Directive, introducing new requirements and definitions. Planning for these IVD regulatory changes is essential for compliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Center for Devices and Radiological health: an update.

Medical device technology·2005
Same author

Notified Body guidance on clinical evaluation.

Medical device technology·2004
Same author

Drug delivery systems: avoiding the pitfalls.

Medical device technology·2004
Same author

New FDA guidance on electronic records and signatures.

Medical device technology·2003
Same author

Update on the European database.

Medical device technology·2003
Same author

An important step forward in the global harmonisation of premarket review programmes.

Medical device technology·2003

Area of Science:

  • Medical Device Regulation
  • In Vitro Diagnostic Devices
  • European Union Directives

Background:

  • Article 21 of the In Vitro Diagnostic (IVD) Directive (98/79/EC) introduced significant amendments to the Medical Device (MD) Directive (93/42/EEC).
  • These amendments are crucial but often overlooked in discussions concerning MD Directive requirements.
  • A clear understanding of these changes is vital for manufacturers and regulatory bodies.

Purpose of the Study:

  • To review the key amendments introduced by Article 21 of the IVD Directive to the MD Directive.
  • To highlight the importance of these amendments in the current regulatory landscape.
  • To provide the updated definition of In Vitro Diagnostic products.

Main Methods:

  • Review of legislative documents, specifically Article 21 of the IVD Directive and the MD Directive.
  • Comparative analysis of the original MD Directive requirements and the amendments introduced by the IVD Directive.
  • Synthesis of information to present a clear overview of the changes.

Main Results:

  • Article 21 of the IVD Directive significantly impacts the MD Directive, necessitating updated compliance strategies.
  • The amendments include changes to definitions, classification, and conformity assessment procedures.
  • A new definition for IVD products is presented within the context of these amendments.

Conclusions:

  • Manufacturers and stakeholders must proactively plan for the implementation of Article 21 amendments.
  • Awareness and understanding of these regulatory updates are critical for continued market access.
  • The revised definition of IVD products requires careful consideration in product development and classification.

Related Experiment Videos